![]() |
|||
|
|
|
|
| UPDATE: August 2007 | MW: 360.49 | MF: C21H28O5 |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
parenteral | silkworm
100 µmol/L
|
ENZYAS 41,183,1971
|
DNA adduct
|
human
liver
|
2 mmol/L
|
MUREAV 370,49,1996
|
DNA adduct
|
human
liver
|
2 mmol/L/1 hour
|
MUREAV 370,49,1996
|
DNA adduct
|
human
liver
|
2 mmol/plate/1 hour
|
MUREAV 370,49,1996
|
DNA damage
|
mammal (species unspecified)
liver
|
1 mmol/L
|
ENZYAS 41,183,1971
|
DNA damage
|
mammal (species unspecified)
lymphocyte
|
10 µmol/L
|
ENZYAS 41,183,1971
|
DNA damage
|
mouse
liver
|
100 µmol/L
|
ENZYAS 41,183,1971
|
DNA inhibition
|
subcutaneous | rat
168 mg/kg/3 day- continuous
|
ENDOAO 94,1637,1974
|
unscheduled DNA synthesis
|
subcutaneous | rat
168 mg/kg/3 day- continuous
|
ENDOAO 94,1637,1974
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intramuscular | mouse
lowest published toxic dose: 400 mg/kg (11-14 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
JDREAF 50,609,1971
|
intramuscular | mouse
lowest published toxic dose: 100 mg/kg (11-12 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
ANREAK 142,479,1962
|
intramuscular | mouse
lowest published toxic dose: 300 mg/kg (12 day pregnant)
|
Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth) | Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive) Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
JTEHD6 10,541,1982
|
intramuscular | mouse
lowest published toxic dose: 300 mg/kg (12 day pregnant)
|
Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive) | Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) Reproductive: Effects on newborn: Physical
TCMUD8 4,403,1984
|
intramuscular | rat
lowest published toxic dose: 110 mg/kg (1-22 day pregnant)
|
Reproductive: Effects on newborn: Delayed effects
|
JCINAO 41,710,1962
|
intramuscular | rat
lowest published toxic dose: 225 mg/kg (13-22 day pregnant)
|
Reproductive: Specific developmental abnormalities: Blood and lymphatic systems (including spleen and marrow)
|
ACENA7 50,104,1965
|
intramuscular | rat
lowest published toxic dose: 110 mg/kg (1-22 day pregnant)
|
Reproductive: Specific developmental abnormalities: Endocrine system
|
ACENA7 53,547,1966
|
intramuscular | rat
lowest published toxic dose: 82,500 µg/kg (11 day pregnant)
|
Reproductive: Other effects to embryo or fetus | Reproductive: Specific developmental abnormalities: Endocrine system Reproductive: Effects on newborn: Biochemical and metabolic
ACENA7 60,36,1969
|
intraperitoneal | mouse
lowest published toxic dose: 400 mg/kg (11-14 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
JDREAF 50,609,1971
|
intraperitoneal | mouse
lowest published toxic dose: 200 mg/kg (11 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
JDREAF 45,1767,1966
|
oral | mouse
lowest published toxic dose: 500 mg/kg (6-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
28QFAD -,85,1973
|
oral | mouse
lowest published toxic dose: 1 gm/kg (6-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system
|
JJATDK 5,97,1985
|
oral | woman
lowest published toxic dose: 90 mg/kg (90 day pregnant)
|
Reproductive: Specific developmental abnormalities: Eye, ear | Reproductive: Specific developmental abnormalities: Musculoskeletal system Reproductive: Specific developmental abnormalities: Cardiovascular (circulatory) system
AJOGAH 65,227,1953
|
oral | woman
lowest published toxic dose: 160 mg/kg (16 week prior to copulation/1-39 week pregnant)
|
Reproductive: Effects on newborn: Other neonatal measures or effects
|
OBGNAS 1,276,1953
|
parenteral | rat
lowest published toxic dose: 35 mg/kg (7 day prior to copulation)
|
Reproductive: Maternal effects: Uterus, cervix, vagina
|
JEMEAV 102,347,1955
|
parenteral | rabbit
lowest published toxic dose: 32 mg/kg (20-27 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Effects on embryo or fetus: Fetal death
JOENAK 14,284,1956
|
subcutaneous | mouse
lowest published toxic dose: 400 mg/kg (11-14 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
JDREAF 50,609,1971
|
subcutaneous | rat
lowest published toxic dose: 500 mg/kg (8-17 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
AGDJAI 18,34,1970
|
unreported route | mouse
lowest published toxic dose: 120 mg/kg (1 day prior to copulation)
|
Reproductive: Effects on fertility: Other measures of fertility
|
FESTAS 12,346,1961
|
unreported route | rat
lowest published toxic dose: 144 mg/kg (9 day male)
|
Reproductive: Effects on fertility: Mating performance (e.g., # sperm positive females per # females mated; # copulations per # estrus cycles)
|
ANENAG 24(Suppl 3),1,1963
|
unreported route | rabbit
lowest published toxic dose: 450 mg/kg (16-30 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
AKGIAO 43(12),10,1967
|
unreported route | woman
lowest published toxic dose: 476 mg/kg (1-34 week pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
LANCAO 2,730,1956
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
parenteral | rabbit
lowest published toxic dose: 35 mg/kg/7 day- intermittent
|
Liver: Hepatitis (hepatocellular necrosis), zonal | Liver: Other changes Liver: Changes in liver weight
ANREAK 113,349,1952
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
TOXICOLOGY REVIEW
|
|
AJOGAH 96,985,1966
|
TOXICOLOGY REVIEW
|
|
PHTHDT 96,23,2002
|
TOXICOLOGY REVIEW
|
|
LANCAO 1,1045,1956
|
TOXICOLOGY REVIEW
|
|
AINCM* 7,63,2006
|
TOXICOLOGY REVIEW
|
|
ENTOX* -,669,2005
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X3836 |
Number of Industries 1; Total Number of Facilities 27; Number of Occupations 1; Total Number of Employees Exposed 936; Total Number of Female Employees Exposed 906 | |||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
N/R
|
| ||
REFERENCES:
CODEN
|
|
REFERENCE
28QFAD
|
"Laboratory Animals in Drug Testing, Symposium of the 5th International Committee on
Laboratory Animals, Hanover, 1972," Speigel, A. ed., Stuttgart, Fed. Rep. Ger., Gustav Fischer
Verlag, 1973
|
ACENA7
|
Acta Endocrinologica (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) V.1-
1948-
|
AGDJAI
|
Journal of the Academy of General Dentistry. (Academy of General Dentistry, 211 E. Chicago
Ave., Suite 1200, Chicago, IL 60611) V.1- 1952(?)-
|
AINCM*
|
Anaesthesia and Intensive Care Medicine (Abingdon: Medicine Pub. Co.) V.1- 2000-
|
AJOGAH
|
American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial
Dr., St. Louis, MO 63146) V.1- 1920-
|
AKGIAO
|
Akushcherstvo i Ginekologiya (Moscow). (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1-
1936-
|
ANENAG
|
Annales d'Endocrinologie. (Masson Editeur, 120 Blvd. Saint-Germain, F-25280 Paris Cedex 06,
France) V.1- 1939-
|
ANREAK
|
Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08-
|
ENDOAO
|
Endocrinology (Baltimore). (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21203)
V.1- 1917-
|
ENTOX*
|
Encyclopedia of Toxicology: Reference Book, Elsevier, 2005
|
ENZYAS
|
Enzymologia. (The Hague, Netherlands) V.1-43, 1936-72.
|
FESTAS
|
Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282)
V.1- 1950-
|
JCINAO
|
Journal of Clinical Investigation. (Rockefeller Univ. Press, 1230 York Ave., New York, NY
10021) V.1- 1924-
|
JDREAF
|
Journal of Dental Research. (International Assoc. for Dental Research, 734 15th St., NW,
Suite 809, Washington, DC 20005) V.1- 1919-
|
JEMEAV
|
Journal of Experimental Medicine. (Rockefeller Univ. Press, 1230 York Ave., New York, NY
10021) V.1- 1896-
|
JJATDK
|
JAT, Journal of Applied Toxicology. (John Wiley & Sons Ltd., Baffins Lane, Chichester, W.
Sussex PO19 1UD, UK) V.1- 1981-
|
JOENAK
|
Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester,
Essex CO2 8HP, UK) V.1- 1939-
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
LANCAO
|
Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
OBGNAS
|
Obstetrics and Gynecology. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY
10017) V.1- 1953-
|
PHTHDT
|
Pharmacology and Therapeutics. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW,
UK) V.4- 1979-
|
TCMUD8
|
Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New
York, NY 10003) V.1- 1980-
|
| |